Key Takeaways
- Strong volume-led quarter, one-off provision hits PAT: Revenue grew ~19% YoY to ₹623 cr on ~28% volume expansion, but PAT collapsed 81% to ₹2 cr due to a ₹40 cr exceptional gratuity provision from wage code implementation.
- Exports and seeds are the growth engines: B2B exports surged 73% YoY on volume and customer expansion, while the seeds business grew 46% YoY, both materially outpacing the 13% domestic B2C growth.
- Pricing power remains absent: A ~8% pricing decline partially offset volume gains, as global competition, Chinese supply, and liquidation of near-expiry domestic materials continue to cap realizations.
- Management lays out a 5-year aspiration, not a forecast: The ambition is double-digit revenue growth and a 500 bps blended margin expansion over five years, with seeds reaching ₹1,000 cr and soil & plant health growing 4x.
- What to watch next quarter: Whether the Chinese VAT rebate discontinuation in April triggers pre-buying or dumping that disrupts Q4, and any early signal on cotton seed pricing for the upcoming season.
Topline & Profitability
- Revenue growth was volume-led: The ~19% YoY revenue increase to ₹623 cr was driven by ~28% volume expansion, partially offset by an ~8% price decline, reflecting limited pricing power in a competitive environment.
- PAT wiped out by a one-off provision: PAT fell 81% YoY to ₹2 cr, entirely due to a ₹40 cr exceptional gratuity provision linked to the new wage code; underlying operational performance was stronger.
- EBITDA grew healthily: EBITDA rose 29% YoY to ₹58 cr, indicating that the core business generated meaningful operating leverage from the volume surge.
- Nine-month trajectory is more muted: For 9M FY26, topline grew 9% YoY to ₹2,441 cr, with Crop Care at 8% and B2C at just 3%, suggesting Q3 was an acceleration rather than the steady-state run rate.
- Inventory is slightly elevated: Inventory levels are marginally higher than the same quarter last year, though management noted that collections remain smooth.
Segment Performance
| Segment | Trend | Commentary |
|---|---|---|
| B2B Exports | ▲ Strong | 73% YoY growth to ₹129 cr on volume growth, customer base expansion, and improved capacity utilization; margin expansion has been significant, exceeding 20%. |
| Seeds | ▲ Strong | 46% YoY growth to ₹43 cr driven by paddy, mustard and wheat volumes; healthy product placements in paddy. |
| CSM | ▲ Positive | 26% growth to ₹46 cr with a positive run rate; small opportunities in hand at different execution stages, some contributing from FY27 onward. |
| Domestic B2C | ▲ Moderate | 13% growth to ₹391 cr on 25% volume growth, but negative price impact from liquidation of near-expiry materials; strong fungicide performance in potato and cumin. |
| Crop Care (overall) | ▲ Solid | 18% growth to ₹580 cr, driven by volume expansion, new product promotion, and increased digital engagement. |
| Soil & Plant Health | ▲ Steady | 16% growth to ₹73 cr with both price and volume growth; compliance progressed after successful migration of bio-stimulant production in-house. |
- Kharif was a setback: Excessive rain in August and September caused missed sprays, hurting companies operating in soybean and cotton herbicide segments; this weighed on the 9M B2C growth of just 3%.
- Rabi was better: The rabi season outperformed the previous one, with Rallis doing particularly well in potato and cumin crops through its fungicide portfolio.
- Seed business faced supply challenges: Last year's seed production crop was planted late, causing all crops to mature simultaneously, which led to supply delays and early rains; despite this, revenue still grew 5% in the quarter (15% YoY for 9M).
Shukla: "Aspirationally, I want to grow company in double digit from a revenue perspective and expand the margin on an overall blended basis to 500 basis points in 5 years."
Exports & China Dynamics
- Export recovery is volume-led, not price-led: Global inventories are normalizing gradually, but realizations remain capped by intense competition with China as the primary supplier; a weaker currency provides some cushion but does not offset broad price pressure.
- Capacity utilization improved: Higher export volumes have driven better plant utilization across all facilities, a significant improvement over last year.
- China VAT rebate uncertainty looms: The discontinuation of China's VAT export rebate takes effect from April; management is waiting for details on how much China has already supplied ahead of the change and could not quantify the impact or exposure.
- Dependence on China is structural: Management acknowledged that dependence on China for technical procurement will continue and that the strategy is to have more partners in China to ensure continued access, not to replace Chinese supply.
- Q4 dumping risk was sidestepped: When asked whether anticipated dumping from China could impact Q4, management did not directly address the risk, stating only that Q4 is planned as a normal quarter driven by seasonal demand.
Shukla: "The challenge is not that all of that can be replaced. Not only it is there, it will continue to be there."
Product & Digital Initiatives
- New product launch momentum is building: 'Fateh Nxt' herbicide was launched in Q3; across 9M FY26, nine new products were introduced (seven herbicides, two fungicides).
- NuCode platform targets biologicals: A new brand under Soil & Plant Health, NuCode, covers bio-fertilizers, bio-stimulants and bio-pesticides, with products in different categories showing good traction.
- Idea2Impact opens the innovation funnel: An open-innovation platform was unveiled to co-create, validate and scale farmer-centric solutions by inviting startups, researchers and partners; it aims to accelerate innovation for those who lack resources to scale independently.
- Sampark Plus app digitizes field operations: Launched just before the call, this unified platform acts as a demand-creation tool for both seeds and crop care, connecting villages up to retailers and distributors for targeted engagement.
- Two patents were granted: An Indian patent for a three-way herbicide combination for wheat (Metsulfuron Methyl + Clodinafop-Propargyl + Metribuzin) and a US patent for the Mesotrione process strengthen the IP portfolio.
- Partnership with Paryan Alliance: Announced for FullPage herbicide-tolerant rice technology in India, expanding the seeds-and-traits toolkit.
Regulatory Tailwinds
- Draft Pesticides Management Bill, 2025 is a structural positive: Referencing quality controls, lab accreditation, digital traceability and stiffer penalties, the bill raises compliance costs for unorganized players and favors organized incumbents like Rallis.
- Proposed Seeds Bill raises entry barriers: Measures including registration and QR tagging keep compliance in focus and are expected to raise barriers to entry over the medium term.
- Biofertilizer registration is progressing: When asked about regulatory speed, management said "you can't say speed" but confirmed that the registration process "is sorted for us," implying Rallis has navigated it successfully.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Blended margin expansion | Expand overall blended EBITDA margin by 500 bps | Over 5 years |
| Seeds revenue aspiration | Grow seeds business closer to ₹1,000 cr | Over 5 years |
| Soil & Plant Health aspiration | Grow business 4x from ₹225 cr to ₹700-800 cr | Over 5 years |
| Capex discipline | No significant capex ahead of market demand unless a firm contract is in place; only sustainable capex planned | Ongoing |
| Q4 planning | Normal quarter driven by seasonal demand; no advancing or delaying sales | Q4 FY26 |
Key Metrics
| Metric | Q3 FY26 |
|---|---|
| Revenue | ₹623 cr, +19% YoY; volume growth ~28%, pricing de-growth ~8% |
| EBITDA | ₹58 cr, +29% YoY |
| Profit after tax | ₹2 cr, -81% YoY vs ₹11 cr in Q3FY25 |
| Exceptional item (gratuity provision) | ₹40 cr, on account of wage code implementation |
| Crop Care segment revenue | ₹580 cr, +18% YoY from ₹492 cr |
| Seeds segment revenue | ₹43 cr, +46% YoY from ₹30 cr |
| Soil & Plant Health revenue | ₹73 cr, +16% YoY from ₹62 cr |
| Exports (B2B) revenue | ₹129 cr, +73% YoY from ₹75 cr |
| CSM revenue | ₹46 cr, +26% YoY from ₹37 cr |
| Domestic (B2C) revenue | ₹391 cr, +13% YoY; volume +25%, price -12% |
| 9M FY26 revenue | ₹2,441 cr, +9% YoY |
| 9M FY26 Seeds revenue | ₹450 cr, +15% YoY |
| Cash and liquid balance | ₹455 cr as of December 31, 2025 |
| China procurement dependence | More than 40% of technical procurement on a blended basis |